180
Views
18
CrossRef citations to date
0
Altmetric
Articles

A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma

, , , , , , & show all
Pages 25-29 | Published online: 04 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Heiner Adams, Ellen C Obermann, Stephan Dirnhofer & Alexandar Tzankov. (2011) Targetable molecular pathways in classical Hodgkin's lymphoma. Expert Opinion on Investigational Drugs 20:2, pages 141-151.
Read now

Articles from other publishers (17)

Hao Guo, Jingyi Yang, Haoran Wang, Xingchen Liu, Yanyan Liu & Keshu Zhou. (2022) Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms. Frontiers in Immunology 13.
Crossref
Paula Garcia-Oliveira, Paz Otero, Antia Gonzalez Pereira, Franklin Chamorro, Maria Carpena, Javier Echave, Maria Fraga-Corral, Jesus Simal-Gandara & Miguel Angel Prieto. (2021) Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment. Pharmaceuticals 14:2, pages 157.
Crossref
Christopher Heim, Dimanthi Pliatsika, Farnoush Mousavizadeh, Kerstin Bär, Birte Hernandez Alvarez, Athanassios Giannis & Marcus D. Hartmann. (2019) De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives. Journal of Medicinal Chemistry 62:14, pages 6615-6629.
Crossref
Young Wha Koh, Jae-Ho Han, Dok Hyun Yoon, Cheolwon Suh & Jooryung Huh. (2018) Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma. Hematological Oncology 36:1, pages 182-188.
Crossref
Rajendra Gharbaran. (2016) Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs—syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin’s lymphoma. Tumor Biology 37:9, pages 11573-11588.
Crossref
Christian Marinaccio, Beatrice Nico, Eugenio Maiorano, Giorgina Specchia & Domenico Ribatti. (2014) Insights in Hodgkin Lymphoma angiogenesis. Leukemia Research 38:8, pages 857-861.
Crossref
Miao Xu, Yu Hou, Lei Sheng & Jun Peng. (2013) Therapeutic effects of thalidomide in hematologic disorders: a review. Frontiers of Medicine 7:3, pages 290-300.
Crossref
Jieun Uhm & John Kuruvilla. (2012) Treatment of newly diagnosed advanced stage Hodgkin lymphoma. Blood Reviews 26:4, pages 167-174.
Crossref
Panayotis Kaloyannidis, Georgia Voutiadou, Ioannis Baltadakis, Panagiotis Tsirigotis, Alexandros Spyridonidis, Panagiotis Repousis, Artemisia Balta, Simeon Tsimberis, Dimitrios Karakasis, Ioanna Sakellari, Ioannis Dervenoulas, Nicholas Harhalakis & Achilles Anagnostopoulos. (2012) Outcomes of Hodgkin’s Lymphoma Patients with Relapse or Progression following Autologous Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 18:3, pages 451-457.
Crossref
John Kuruvilla, Armand Keating & Michael Crump. (2011) How I treat relapsed and refractory Hodgkin lymphoma. Blood 117:16, pages 4208-4217.
Crossref
Gerhard Sissolak, Dagmar Sissolak & Peter Jacobs. (2010) Human immunodeficiency and Hodgkin lymphoma. Transfusion and Apheresis Science 42:2, pages 131-139.
Crossref
R. García‐Sanz, T.J. González‐López, L. Vázquez, G. Hermida, I.F. Graciani & J.F. San Miguel. (2010) The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin’s lymphoma. European Journal of Haematology 84:3, pages 266-270.
Crossref
Michael Medinger, Natalie Fischer & Alexandar Tzankov. (2010) Vascular Endothelial Growth Factor-Related Pathways in Hemato-Lymphoid Malignancies. Journal of Oncology 2010, pages 1-13.
Crossref
Annika Bundscherer & Christian Hafner. 2010. From Molecular to Modular Tumor Therapy. From Molecular to Modular Tumor Therapy 483 503 .
Nancy L Bartlett. (2008) Modern treatment of Hodgkin lymphoma. Current Opinion in Hematology 15:4, pages 408-414.
Crossref
Michael Crump. (2008) Management of Hodgkin Lymphoma in Relapse after Autologous Stem Cell Transplant. Hematology 2008:1, pages 326-333.
Crossref
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:3, pages 166-173.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.